Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

GenMark Diagnostics Inc (NASDAQ:GNMK)

During the Trading Day
7.58 +0.30 / +4.12%
As of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
7.52 -0.059 / -0.78%
Volume: 400.00
Health Technology
Medical Specialties

Company Description

GenMark Diagnostics, Inc. is a molecular diagnostics company which focuses on developing and commercializing its proprietary eSensor detection technology. The company's eSensor XT-8 system is an automated molecular diagnostic system that enables reference laboratories and hospitals to perform fast, accurate and easy-to-use molecular diagnostic tests. It operates in one business segment, which is the development and commercialization of molecular tests based on its proprietary eSensor detection technology. The company was founded by Jon Faiz Kayyem on February 12, 2010 and is headquartered in Carlsbad, CA.

Contact Information

GenMark Diagnostics, Inc.
5964 La Place Court
Carlsbad California 92008-8829
P:(760) 448-4300
Investor Relations:



Individual stakeholders7.68%
Mutual fund holders63.47%
Other institutional40.15%

Top Executives

Hany MassaranyPresident, Chief Executive Officer & Director
Scott MendelChief Financial Officer
Jon Faiz KayyemSenior Vice President-Research & Development
Eric J. StierSecretary, Senior Vice President & General Counsel
Michael GleesonSenior VP-North American Commercial Operations